Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1

Atherosclerosis

Volumn 186, Issue 1, 2006, Pages 65-73

  Kitajima, Ken ^a   Marchadier, Dawn H L ^a   Burstein, Haim ^b   Rader, Daniel J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Targeted Genetics Corporation   (United States)

Author keywords

Adeno associated virus; Apolipoprotein A l; Gene transfer; High density lipoprotein cholesterol

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARVOVIRUS VECTOR; THYROXINE BINDING GLOBULIN;

ADENOASSOCIATED VIRUS SEROTYPE 1; ADENOASSOCIATED VIRUS SEROTYPE 2; ADENOASSOCIATED VIRUS SEROTYPE 5; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STABILITY; DRUG TARGETING; FEMALE; GENE TRANSFER; GENETIC CODE; HYPOTHESIS; LIVER; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; TAIL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; APOLIPOPROTEIN A-I; CORONARY DISEASE; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LIVER; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTYPING;

EID: 33645872985     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.07.009     Document Type: Article

References (25)

1. Rader D.J. High-density lipoproteins and atherosclerosis. Am J Cardiol 90 (2002) 62i-70i
2. Barter P., Kastelein J., Nunn A., and Hobbs R. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168 (2003) 195-211
3. Benoit P., Emmanuel F., Caillaud J.M., et al. Somatic gene transfer of human ApoA-l inhibits atherosclerosis progression in mouse models. Circulation 99 (1999) 105-110
4. Van Linthout S., Collen D., and De Geest B. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-l. Hum Gene Ther 13 (2002) 829-840
5. Tangirala R.K., Tsukamoto K., Chun S.H., et al. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-l in mice. Circulation 100 (1999) 1816-1822
6. Mingozzi F., Schuttrumpf J., Arruda V.R., et al. Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector. J Virol 76 (2002) 10497-10502
7. Snyder R.O., Miao C., Meuse L., et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5 (1999) 64-70
8. Chen S.J., Rader D.J., Tazelaar J., et al. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther 2 (2000) 256-261
9. Samulski R.J., Berns K.L., Tan M., and Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci USA 79 (1982) 2077-2081
10. Srivastava A., Lusby E.W., and Berns K.I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 45 (1983) 555-564
11. Auricchio A., O'Connor E., Weiner D., et al. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J Clin Invest 110 (2002) 499-504
12. Auricchio A., Kobinger G., Anand V., et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet 10 (2001) 3075-3081
13. Rabinowitz J.E., Rolling F., Li C., et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76 (2002) 791-801
14. Sandalon Z., Bruckheimer E.M., Lustig K.H., et al. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol 78 (2004) 12355-12365
15. Hayashi Y., Mori Y., Janssen O.E., et al. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation. Mol Endocrinol 7 (1993) 1049-1060
16. Rouet P., Raguenez G., Tronche F., et al. A potent enhancer made of clustered liver-specific elements in the transcription control sequences of human alpha 1-microglobulin/bikunin gene. J Biol Chem 267 (1992) 20765-20773
17. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
18. Daly T.M., Vogler C., Levy B., et al. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 96 (1999) 2296-22300
19. Chao H., Mao L., Bruce A.T., and Walsh C.E. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 95 (2000) 1594-1599
20. Chao H., Liu Y., Rabinowitz J., et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2 (2000) 619-623
21. Jung S.C., Han I.P., Limaye A., et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA 98 (2001) 2676-2681
22. Monahan P.E., and Samulski R.J. AAV vectors: is clinical success on the horizon?. Gene Ther 7 (2000) 24-30
23. Carter B.J., Burstein H., and Peluso R.W. Adeno-associated virus and AAV vectors for gene therapy. In: Templeton N.S. (Ed). Gene and cell therapy: therapeutic mechanisms and strategies. 2nd ed. (revised and expanded) (2004), Marcel Dekker, New York, NY 71-101
24. Xiao W., Chirmule N., Berta S.C., et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 73 (1999) 3994-4003
25. Hauck B., Chen L., and Xiao W. Generation and characterization of chimeric recombinant AAV vectors. Mol Ther 7 (2003) 419-425